Chad vs Guyana: Access to anti-retroviral drugs, male
Chad
67.0%
in 2024
Guyana
66.0%
in 2024
Chad rank
78th
Guyana rank
80th
Access to anti-retroviral drugs, male over time
- Chad
- Guyana
How they compare
Chad currently reports 67.0% against 66.0% in Guyana, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Guyana ahead.
Chad ranks 78th and Guyana ranks 80th of 141 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 16.4% | 13.3% | Guyana |
| 2010s | 25.3% | 49.2% | 23.9% | Guyana |
| 2020s | 55.0% | 60.8% | 5.8% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Chad or Guyana?
- Chad, at 67.0% against 66.0% in Guyana as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Chad and Guyana?
- 1.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Guyana?
- 25 years are reported by both, from 2000 to 2024.
- How do Chad and Guyana rank globally for access to anti-retroviral drugs, male?
- Chad ranks 78th and Guyana ranks 80th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.